What The Study Did: In this study of return-to-play cardiac testing performed on 789 professional athletes with COVID-19 infection, imaging evidence of inflammatory heart disease that resulted in restriction from play was identified in five athletes (0.6%). No adverse cardiac events occurred in the athletes who underwent cardiac screening and resumed professional sports participation.
Authors: David J. Engel, M.D., of Columbia University Irving Medical Center in New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamacardio.2021.0565)
Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2021.0565?guestAccessKey=d2d41b6d-0b2a-46b1-8bff-4e71e29697b5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030421 "> https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2021.0565?guestAccessKey=d2d41b6d-0b2a-46b1-8bff-4e71e29697b5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=0304
JAMA Cardiology